Insulin Pump Market - By Product [Devices (Tubed/tethered, Tubeless), Accessories (Battery, Insulin Reservoir or Cartridges, Insulin Set Insertion Devices)], End-use (Home Care, Hospitals & Clinics) – Global Forecast, 2024 – 2032

Insulin Pump Market Size

Insulin Pump Market size was valued at around USD 5.3 billion in 2023 and is expected to grow with a CAGR of 12.4% from 2024 to 2032. The high market growth can be attributed to various factors including growing awareness and education, rising prevalence of diabetes, patient preference for insulin pump therapy and technological advancements among others. Supportive government initiatives and reimbursement policies for diabetes care devices, including insulin pumps, will further stimulate market growth.
 

The increasing prevalence of diabetes globally, particularly type 1 diabetes and insulin-dependent type 2 diabetes, is a significant driver. As more people are diagnosed with diabetes, there is a growing demand for advanced and effective insulin delivery systems. For example, as per the statistics reported by International Diabetes Federation, there were around 537 million people aged between 20-79 years had diabetes globally. This number is expected to reach around 783 million by 2045, an increase of 46%. Thus, presence of such high target population base will result in increased demand for insulin delivery devices including insulin pumps.
 

An insulin pump is a medical device designed to administer a continuous supply of insulin to individuals with diabetes. Worn externally, the pump delivers precise doses throughout the day, mimicking the function of a healthy pancreas. It offers improved blood glucose control and greater flexibility in insulin management compared to traditional injection methods.
 

Insulin Pump Market Trends

Technological advancements in insulin pumps are contributing to improved diabetes management, enhanced patient satisfaction, and increased adoption of insulin pump therapy. Advances in miniaturization have led to smaller and quieter insulin pumps, making them more comfortable for users to wear throughout the day.
 

• Smart insulin pumps often come with connectivity features, allowing users to monitor and control the device through smartphone apps. This enhances convenience and accessibility for users, enabling them to manage their diabetes discreetly.
   
• Integration with continuous glucose monitoring (CGM) systems allows real-time monitoring of glucose levels. This enables more precise insulin delivery, reducing the risk of hypoglycemia and improving overall glucose control.
   
• Insulin pumps are equipped with data storage capabilities, allowing users and healthcare professionals to analyze trends in glucose levels over time. This data-driven approach helps in making informed decisions about insulin dosages and overall digital diabetes management.
   

Insulin Pump Market Analysis

The market by product is categorized into devices and accessories. The devices segment accounted for dominating share and was valued at USD 4.5 billion revenue in 2023. The devices segment is further bifurcated into tubed/tethered, and tubeless segments.
 

• Tubed pumps offer continuous insulin delivery, which is essential for maintaining basal insulin levels throughout the day. This continuous infusion closely mimics the physiological insulin release in a healthy pancreas.
   
• Tubeless insulin pumps are designed to be user-friendly, with simple insertion processes and minimal steps for activation. This ease of use is attractive to individuals who may be new to pump therapy or prefer a straightforward approach.
   
• Further, the demand for tubeless pumps is consistently increasing as these pumps may reduce the risk of occlusions, as there is no tubing that can be blocked or kinked. This is anticipated to contribute to improved reliability in insulin delivery for patients.
   

The insulin pump market by end-use is categorized into home care, hospitals & clinics, and other end-users. The home care segment accounted for around USD 3 billion revenue size in 2023.
 

• Homecare settings empower patients to take an active role in their diabetes management. Insulin pumps, with their user-friendly interfaces and educational support, promote patient engagement and self-efficacy in insulin therapy.
   
• Technological advancements, such as the development of smaller, more discreet pumps with improved user interfaces, contribute to the adoption of insulin pumps in homecare.
   
• Insulin pumps reduce the need for multiple daily injections, providing a more comfortable and less invasive option for insulin delivery. This reduction in the injection burden is especially beneficial for individuals who manage their diabetes at home.
   

North America insulin pump market accounted for USD 2.3 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• Reimbursement policies and coverage for insulin pumps by healthcare insurers in North America can significantly impact market growth. Improved reimbursement options make insulin pump therapy more accessible and affordable for patients.
   
• Additionally, recommendations from healthcare professionals, including endocrinologists and diabetes educators, play a crucial role in driving the adoption of insulin pumps. Positive feedback and endorsements from healthcare providers contribute to increased patient acceptance.
   
• The need for effective and convenient insulin delivery systems is growing as more individuals are diagnosed with diabetes in the region. For instance, according to The National Diabetes Statistics Report, 2022 over 37 million people (around 11.3% of the total population) has diabetes in the U.S. in 2019. This data is expected to rise substantially, thereby, propelling the industry expansion.
   

Insulin Pump Market Share

The insulin pump industry is consolidated in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness is among a key market strategy for manufacturers. Some of the leading industry players including Medtronic plc, Insulet Corporation, Tandem Diabetic Care Inc., MicroPort Scientific Corporation and Ypsomed, among others have a significant presence in the market.
 

Insulin Pump Market Companies

Some of the eminent market participants operating in the insulin pump industry include:

• Debiotech S.A.
• F. Hoffmann La Roche AG
• Insulet Corporation
• Lenomed Medical
• Medtronic plc
• MicroPort Scientific Corporation
• Nipro Corporation
• Tandem Diabetic Care Inc.
• Terumo Corporation
• ViCentra B.V.
• Ypsomed
   

Insulin Pump Industry News:

• In January 2024, Abbott and Tandem Diabetes Care, Inc. recently announced that the t:slim X2 insulin pump with Control-IQ technology will operate with Abbott's latest continuous glucose monitoring (CGM) technology, the FreeStyle Libre 2 Plus sensor. For the first time, FreeStyle Libre technology users in the U.S. could benefit from a hybrid closed-loop system that predicts and prevents high and low blood sugar levels. This development will allow the company to improve its revenue generation.
   
• In April 2023, Medtronic plc announced that the MiniMed 780G system with the Guardian 4 sensor, that needs no fingerstick while using SmartGuard technology, has been approved by the U.S. Food and Drug Administration (U.S. FDA). The technology administers insulin to compensate for instances where users neglect to bolus or overestimate the quantity of carbohydrates in their meal. This development will enable company to expand its userbase as well as product portfolio.
   

Insulin pump market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Devices
  • Tubed/tethered
  • Tubeless
• Accessories
  • Battery
  • Insulin reservoir or cartridges
  • Insulin set insertion devices

Market, By End-use

• Home care
• Hospitals & clinics
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa